Minnesota’s economy—and identity—have been linked for decades to the strength of its life science community, from groundbreaking research at the University of Minnesota to global Fortune 500 companies like Medtronic and General Mills.
But the state is losing its competitive edge, and staying above average is going to require targeted planning and investment in key areas, according to a recent report by the BioBusiness Alliance of Minnesota and Deloitte Consulting.
“Destination 2025 Roadmap: Recommendations To Grow Minnesota’s Life Science Industry” is a 20-year strategic plan based on input from more than 600 public, private and academic experts. (Continue reading…)
Post a Comment